分组 | 对照组(n = 45) | 观察组(n = 45) | P值 | |
年龄 | 61.31 ± 9.25 | 60.67 ± 9.71 | 0.748 | |
性别 | 男[例/(%)] | 32 (71.1%) | 31(70.0%) | 0.818 |
女[例/(%)] | 13 (28.9%) | 14(30.0%) | ||
吸烟史[例/(%)] | 26 (57.8%) | 27 (60.0%) | 0.830 | |
饮酒史[例/(%)] | 16 (35.6%) | 18 (40.0%) | 0.664 | |
糖尿病史[例/(%)] | 14 (31.1%) | 15 (33.3%) | 0.822 | |
冠心病史[例/(%)] | 17 (37.8%) | 20 (44.4%) | 0.520 | |
BMI (kg/m2) | 25.28 ± 2.60 | 25.52 ± 3.19 | 0.698 | |
TG (mmol/L) | 1.35 ± 0.53 | 1.26 ± 0.49 | 0.398 | |
TC (mmol/L) | 4.73 ± 0.72 | 4.58 ± 0.65 | 0.287 | |
LDL-C (mmol/L) | 2.80 ± 0.57 | 2.71 ± 0.72 | 0.528 | |
用药时长(天) | 63.78 ± 3.58 | 64.60 ± 4.15 | 0.317 | |
药物使用情况 | - | - | - | |
袢利尿剂 | 28 (62.2%) | 26 (57.8%) | 0.667 | |
螺内酯 | 26 (57.8%) | 25 (55.6%) | 0.832 | |
β受体阻滞剂 | 15 (33.3%) | 13 (28.9%) | 0.649 | |
洋地黄类 | 7 (15.6%) | 8 (17.8%) | 0.777 | |
降压药 | 45 (100%) | 45 (100%) | 1 | |
降肌酐药物 | 19 (42.2%) | 17 (37.8%) | 0.667 | |
α酮酸 | 35 (77.8%) | 36 (80.0%) | 0.796 | |
纠正贫血 | 37 (82.2%) | 39 (86.7%) | 0.561 | |
肾脏替代治疗 | 45 (100%) | 45 (100%) | 1 | |
心功能分级 | - | - | 0.881 | |
II级[例(%)] | 6 (13.3%) | 6 (13.3%) | - | |
III级[例(%)] | 27 (60.0%) | 29 (64.4%) | - | |
IV级[例(%)] | 12 (26.7%) | 10 (22.2%) | - |